Back
Third Harmonic Bio Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
62
THRD
Third Harmonic Bio
Last Price:
14.72
Seasonality Move:
51.91%
Sell
26
NBY
NovaBay Pharmaceuticals
Last Price:
0.50
Seasonality Move:
-14.79%
Buy
62
Third Harmonic Bio (THRD)
is a Buy
Is Third Harmonic Bio a Buy, Sell or Hold?
- The current Third Harmonic Bio [THRD] share price is $13.50. The Score for THRD is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- THRD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
THRD Stock Price Chart
What is Third Harmonic Bio's stock price today?
-
The Third Harmonic Bio share price today is $13.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THRD is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
THRD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 61.06 | Buy |
| Chaikin Money Flow: | 884087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.68 - 12.94) | Buy |
| Bollinger Bands (100): | (11.59 - 13.47) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 38.38 | Sell |
| Chaikin Money Flow: | -38478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.47 - 0.53) | Buy |
| Bollinger Bands (100): | (0.61 - 3.39) | Sell |
THRD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.01 | Buy |
| 20-day SMA: | 12.46 | Buy |
| 50-day SMA: | 12.17 | Buy |
| 200-day SMA: | 11.31 | Buy |
| 8-day EMA: | 12.98 | Buy |
| 20-day EMA: | 12.57 | Buy |
| 50-day EMA: | 12.34 | Buy |
| 200-day EMA: | 11.24 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.48 | Buy |
| 20-day SMA: | 0.49 | Buy |
| 50-day SMA: | 0.89 | Sell |
| 200-day SMA: | 3.84 | Sell |
| 8-day EMA: | 0.49 | Buy |
| 20-day EMA: | 0.53 | Sell |
| 50-day EMA: | 0.97 | Sell |
| 200-day EMA: | 8.42 | Sell |
Third Harmonic Bio Earnings Growth & THRD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.02 per share, an increase this year of $0.17 per share, and a decrease next year of $0.28 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Third Harmonic Bio Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||